Back
Reshape Lifesciences Stock Price Chart
How to hack a $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
16
RSLS
Reshape Lifesciences
Last Price:
$2.56
Seasonality Move:
-37.13%
7 Day Trial
ALL ACCESS PASS
$
7
Former Zillow exec targets $1.3T marke
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RSLS is experiencing slight selling pressure.
Reshape Lifesciences Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.64 | Sell |
| 20-day SMA: | 3.95 | Sell |
| 50-day SMA: | 6.81 | Sell |
| 200-day SMA: | 83.4 | Sell |
| 8-day EMA: | 2.94 | Sell |
| 20-day EMA: | 4.05 | Sell |
| 50-day EMA: | 9.96 | Sell |
| 200-day EMA: | 223.4 | Sell |
Reshape Lifesciences Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.46 | Sell |
| Relative Strength Index (14 RSI): | 36.85 | Sell |
| Chaikin Money Flow: | -37887 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.01 - 5.77) | Sell |
| Bollinger Bands (100): | (-3.9 - 49.38) | Sell |
Reshape Lifesciences Technical Analysis
| Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Reshape Lifesciences Stock
Is Reshape Lifesciences Stock a Buy?
-
Reshape Lifesciences share price is 2.56 while RSLS 8-day simple moving average is 2.64, which is a Sell signal.
-
The stock price of RSLS is 2.56 while Reshape Lifesciences 20-day SMA is 3.95, which makes it a Sell.
-
Reshape Lifesciences 50-day simple moving average is 6.81 while RSLS share price is 2.56, making it a Sell technically.
-
RSLS stock price is 2.56 and Reshape Lifesciences 200-day simple moving average is 83.40, creating a Sell signal.
RSLS Technical Analysis vs Fundamental Analysis
Sell
16
Reshape Lifesciences (RSLS)
is a Sell
Is Reshape Lifesciences a Buy or a Sell?
-
Reshape Lifesciences stock is rated a SellThe current Reshape Lifesciences [RSLS] share price is $2.56. The Score for RSLS is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
Reshape Lifesciences Stock Info
Market Cap:
1.9M
Price in USD:
2.56
Share Volume:
246.3K
Reshape Lifesciences 52-Week Range
52-Week High:
415.00
52-Week Low:
2.23
Sell
16
Reshape Lifesciences (RSLS)
is a Sell
Reshape Lifesciences Share Price Forecast
-
What is the Reshape Lifesciences stock price today?The Reshape Lifesciences stock price is 2.56 USD today.
-
Will RSLS stock go up or go down?Reshape Lifesciences> share price is forecast to RISE/FALL based on technical indicators
-
Is Reshape Lifesciences overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Reshape Lifesciences is overvalued.
Is Reshape Lifesciences Stock a Buy?
-
Reshape Lifesciences share price is 2.56 while RSLS 8-day exponential moving average is 2.94, which is a Sell signal.
-
The stock price of RSLS is 2.56 while Reshape Lifesciences 20-day EMA is 4.05, which makes it a Sell.
-
Reshape Lifesciences 50-day exponential moving average is 9.96 while RSLS share price is 2.56, making it a Sell technically.
-
RSLS stock price is 2.56 and Reshape Lifesciences 200-day simple moving average is 223.40, creating a Sell signal.
Fundamental Analysis of Reshape Lifesciences
Is Reshape Lifesciences a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Reshape Lifesciences
Should I short Reshape Lifesciences stock?
-
RSLS Moving Average Covergence Divergence (MACD) indicator is -1.46, suggesting Reshape Lifesciences is a Sell
-
Reshape Lifesciences Relative Strength Index (RSI) is 36.85, which suggest Reshape Lifesciences is oversold
-
The Bollinger Bands (25) for Reshape Lifesciences is (3.01 - 5.77), which suggest Reshape Lifesciences is a Sell
-
The Bollinger Bands (100) for Reshape Lifesciences is (-3.9 - 49.38), which suggest Reshape Lifesciences is a Sell
* Reshape Lifesciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.